Skip to content

Effect of SGLT2 inhibitor, Dapagliflozin combined with or without metformin on body composition in patients with type 2 diabetes

Effect of SGLT2 inhibitor, Dapagliflozin combined with or without metformin on body composition in patients with type 2 diabetes - Effect of SGLT2 inhibitor combined with metformin on body composition

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030446
Enrollment
54
Registered
2019-01-01
Start date
2017-12-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Orally take a dose of 5mg of dapagliflozin once a day before or after breakfast in addition to the medicines taken at time of consenting. If the blood glucose levels are high in patients after a mont

Sponsors

St. Marianna University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Type 2 diabetic patients with insufficient glycemic control (HbA1c 7.0 to 10.0%) and BMI 22 kg/m2 and over 2)Patients who are administrating more than or equal to 750mg of metformin, or who aren't receiving metformin thrapy 3)over 20 and under 65 years old 4)outpatient 5)male and female

Exclusion criteria

Exclusion criteria: 1)patients who administrating less than 750mg of metformin 2)patients who receive insulin injection therapy 3)hypersensitivity to study drugs on this study, 4)severe ketosis and diabetic coma or pre-coma 5)serious infective diseases, serious injury, pre- and per-operation 6)pregnancy, nursing woman or possibly pregnant woman 7)moderate or severe renal dysfunction (eGFR: less than 30 mL/min/1.73m2) 8)patients who receive steroids, growth hormone secretagogue, sex hormone agents 9)patients who are inadequate to enter this study due to the other reasons by physician's judgments

Design outcomes

Primary

MeasureTime frame
Comparison of the changes in total body muscle mass evaluated by dual-energy x-ray absorptiometry (DXA) before and after 24 weeks between the two groups

Secondary

MeasureTime frame
Comparison of the changes in quadriceps muscle strength measured by a hand-held dynamometer before and after 24 weeks between the two groups

Countries

Japan

Contacts

Public ContactHisashi Fukuda

St. Marianna University School of Medicine Division of Metabolism and Endocrinology, Department of Internal Medicine

h2fukuda@marianna-u.ac.jp044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026